Search This Blog

Monday, December 16, 2019

NewLink rejects Evercel takeover bid

Saying its proposal is “not actionable,”, NewLink Genetics (NLNK -0.6%) has rejected an unsolicited bid from holding company Evercel.
The board continues to believe its previously announced merger with Lumos Pharma is best for shareholders.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)